Претраживање
Приказ резултата 1-1 од 1
Nanonization of new patent protected substances - carrier selection for preclinical research: physicochemical and in vivo behavioral characterization
(10th International Congress Nanotechnology in Medicine & Biology, 15 - 17. April 2019, Graz / Austria, 2019)
Deuterated pyrazoloquinolinones, GABAn receptor ligands, are being investigated for neuropsychiatric disorders treatment. Among others, DK-l-56-1 (7-Methoxy-2-(4-methoxy-d3- p h e n yl ) - 2, 5 -d i h yd ro - 3 H - py r ...